Pig to monkey bone marrow and kidney xenotransplantation

Surgery

Volumn 121, Issue 4, 1997, Pages 381-391

  Sablinski, Tomasz ^a   Gianello, Pierre R ^a   Bailin, Michael ^a   Bergen, Kate S ^a   Emery, David W ^a   Fishman, Jay A ^a   Foley, Alicia ^a   Hatch, Tevis ^a   Hawley, Robert J ^a   Kozlowski, Tomasz ^a   Lorf, Thomas ^a   Meehan, Shane ^a   Monroy, Rod ^a   Powelson, John A ^a   Colvin, Robert B ^a   Cosimi, A Benedict ^a   Sachs, David H ^a,b  

^a BioTransplant Inc   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; STEM CELL FACTOR; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL PROTOCOL; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SPLENECTOMY; SWINE; WHOLE BODY RADIATION; XENOGRAFT; XENOTRANSPLANTATION;

EID: 12644276369     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90307-X     Document Type: Article

References (38)

1. Tanaka M, Latinne D, Gianello P, et al. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 1994;26:1326-7.
2. Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994;43:185-91.
3. Sachs DH, Leight G, Cone J, Schwarz S, Stuart L, Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976;22:559-67.
4. Sachs DH. MHC homozygous miniature swine. In: Swindle MM, Moody DC, Phillips LD, editors. Swine as models in biomedical research. Ames, Iowa: Iowa State University Press, 1992:3-15.
5. Sachs DH, Smith CV, Emery DW, et al. Induction of specific tolerance to MHC-disparate allografts through genetic engineering. Exp Nephrol 1993;1:128-33.
6. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988;46:1-20.
7. Hammer C. Preformed natural antibodies (PNAB) and possibilities of modulation of hyperacute xenogeneic rejection (HXAR). Transplant Proc 1989;21:522-3.
8. Lexer G, Cooper DK, Rose AG, et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 1986;5:411-8.
9. Alexandre GPJ, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, editor. Xenograft 25. New York: Excerpta Medica, 1989:259-66.
10. Leventhal JR, Sakilayak P, Witson J, et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1994;57:974-8.
11. Leventhal JR, RanjitJ, Fryer JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption: results of in vitro and in vivo studies. Transplantation 1995;59:294-300.
12. Pruitt SK, Baldwin WM III, Marsh HC Jr, Lin SS, Yeh CG, Bollinger RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991;52:868-73.
13. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995;1:964-6.
14. Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994;58:1059-66.
15. Gianello PR, Latinne D, Alexandre GPJ. Pig-to-baboon renal xenografts. Xeno 1995;3:26-30.
16. Starzl TE, Murase N, Tsakis A, et al. Clinical xenotransplantation. Xenotransplant 1994;1:3-7.
17. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993;99:265-70.
18. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984;307:168-70.
19. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989;169:493-502.
20. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995;59:256-62.
21. Sharabi Y, Aksentijevich I, Sundt III TM, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a non-lethal preparative regimen. J Exp Med 1990;172:195-202.
22. Latinne D, Gianello P, Smith CV, et al. Xenotransplantation from pig to cynomolgus monkey: approach toward tolerance induction. Transplant Proc 1993;25:336-8.
23. Sablinski T, Latinne D, Gianello P, et al. Xenotransplantation of pig kidneys to nonhuman primates: I. Development of the model. Xenotransplant 1995;2:264-70.
24. Sharabi Y Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992;9:191-7.
25. National Institutes of Health. Guide for the care and use of laboratory animals, publication 85-23, revised 1988. Bethesda, Maryland: National Institutes of Health, 1988.
26. Pennington LR, Sakamoto K, Popitz-Bergez FA, et al. Bone marrow transplantation in miniature swine. I. Development of the model. Transplantation 1988;45:21-6.
27. Emery DW, Shafer GE, Karson EM, Sachs DH, LeGuern C. Retrovirus-mediated transfer and expression of an allogeneic major histocompatibility complex class II DRB cDNA in swine bone marrow cultures. Blood 1993;81:2460-5.
28. Colman RW, Habal M, Hollenberg NK, Birtch AG, Busch GJ. Hyperacute renal allograft rejection in the primate. Am J Pathol 1976;82:25-8.
29. Sachs DH, Sharabi Y, Sykes M. Mixed chimerism and transplantation tolerance. In: Melchers F, Albert EO, von Boehmer H, Dierich MP, Dupasquier I., Eichmann K, et al, editors. Progress in immunology, vol. VII. Berlin/Heidelberg: Springer-Verlag, 1989:1171-6.
30. Aksentijevich I, Sachs DH, Sykes M. Humoral tolerance in xenogeneic BMT recipients conditioned with a non-myeloablative regimen. Transplantation 1992;53:1108-14.
31. Valdivia L, Monden M, Gotoh M, Nakano Y, Tono T, Mori T. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation 1990;50:132-6.
32. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992;54:26-31.
33. Tuso PJ, Cramer DV, Yasunaga C, Cosenza CA, Wu GD, Makowka L. Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and livers. Transplantation 1993;55:1375-8.
34. Fischel RJ, Bolman RM III, Platt JL, Najarian JS, Bach FH, Matas AJ. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. Transplant Proc 1990;22: 1077-8.
35. Norman JC, Brown ME, Saravis CA, Ackyroyd FW, McDermott WV. Perfusion techniques in temporary human-isolated ex vivo porcine liver cross circulation: possible adjunct in the treatment of hepatic failure. J Surg Res 1966;6:121-5.
36. Collins BH, Chari RS, Magee JC, et al. Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure. Transplantation 1994;58:1162-71.
37. Bensinger WI, Baker DA, Buckner CD, Clift RA, Thomas ED. Immunoadsorption for removal of A and B blood-group antibodies. New Engl J Med 1981;304:160-2.
38. Makowka L, Chapman FA, Cramer DV, et al. The role of inflammatory reactions in xenotransplantation. In: Hardy MA, editor. Xenograft 25. New York: Elsevier Science Publishers, 1989:159-75.